An LC–MS/MS‐Based Quantification of Intracellular Anlotinib Reveals Exposure–Toxicity Relationships in Endothelial and Intestinal Epithelial Cells
Biomedical Chromatography · 2026
DOI: 10.1002/bmc.70373 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Zhenhui Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Indoles, Quinolines, Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Shanghai Leading Talent Program of Eastern Talent Plan, the "Shenlan" talent project of Naval Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Local drug exposure is closely associated with both therapeutic efficacy and adverse reactions. Anlotinib is approved for the treatment of chemotherapy‐refractory or metastatic non‐small cell lung cancer; its clinical application is limited by severe adverse reactions, particularly hypertension and diarrhea, and the relationship between intracellular exposure and toxicity remains unclear. In this study, a rapid and sensitive UHPLC–MS/MS method was developed using an Agilent 1290‐6460A ultra‐high performance liquid chromatography coupled to a triple quadrupole mass spectrometer to quantify anlotinib in human intestinal epithelial cells (HIECs) and human umbilical vein endothelial cells (HUVECs). Pazopanib‐d3 was employed as an internal standard, and anlotinib was accurately quantified in 10–4000 ng/mL in positive ionization mode, with acceptable specificity, linearity, accuracy, precision, stability, and dilution integrity. The method was successfully applied to determine intracellular and extracellular anlotinib concentrations in HIECs and HUVECs. Notably, significant differences were observed between intracellular and extracellular concentrations, and intracellular anlotinib concentrations, rather than extracellular concentrations, were positively correlated with cytotoxicity in both cell types. Collectively, this study established a robust analytical approach for intracellular anlotinib quantification and provided experimental evidence linking intracellular exposure to cytotoxicity, offering a foundation for further investigation of anlotinib‐induced adverse reactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
- Department of Pharmacy, Second Affiliated Hospital of Naval Medical University (Shanghai Changzheng Hospital), Shanghai, P. R. China.
- Research and Development Center of Chinese Medicine Resources and Biotechnology, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
ORCID-Profile: Jianguo Sun, Zhipeng Wang, Xia Tao, Shouhong Gao
Förderung
- Shanghai Leading Talent Program of Eastern Talent Plan
- the "Shenlan" talent project of Naval Medical University
- National Natural Science Foundation of China
Zitieren
APA
Jiang, Z., Ye, L., Sun, J., Liu, Z., Xu, J., Li, H., Wang, Z., Tao, X., & Gao, S. (2026). An LC–MS/MS‐Based Quantification of Intracellular Anlotinib Reveals Exposure–Toxicity Relationships in Endothelial and Intestinal Epithelial Cells. Biomedical Chromatography. https://doi.org/10.1002/bmc.70373
Vancouver
Jiang Z, Ye L, Sun J, Liu Z, Xu J, Li H, et al. An LC–MS/MS‐Based Quantification of Intracellular Anlotinib Reveals Exposure–Toxicity Relationships in Endothelial and Intestinal Epithelial Cells. Biomedical Chromatography. 2026. doi:10.1002/bmc.70373
BibTeX
@article{Jiang2026,
author = {Jiang, Zhenhui and Ye, Liya and Sun, Jianguo and Liu, Zhijun and Xu, Jingjie and Li, Huanchen and Wang, Zhipeng and Tao, Xia and Gao, Shouhong},
title = {An LC–MS/MS‐Based Quantification of Intracellular Anlotinib Reveals Exposure–Toxicity Relationships in Endothelial and Intestinal Epithelial Cells},
journal = {Biomedical Chromatography},
year = {2026},
doi = {10.1002/bmc.70373}
}
EUVIMED